114 related articles for article (PubMed ID: 25968074)
1. Is lymph node metastasis of canine grade 2 MCTs justification for adjuvant therapy?
Schulman FY
Vet Comp Oncol; 2015 Jun; 13(2):151. PubMed ID: 25968074
[No Abstract] [Full Text] [Related]
2. Letter to the editor.
Worley DR
Vet Comp Oncol; 2015 Jun; 13(2):152-3. PubMed ID: 25968075
[No Abstract] [Full Text] [Related]
3. Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures.
Worley DR
Vet Comp Oncol; 2014 Sep; 12(3):215-26. PubMed ID: 22958227
[TBL] [Abstract][Full Text] [Related]
4. Pathology in practice. Mast cell tumor (MCT) of the oral mucosa with submandibular lymph node metastasis in a dog.
Pabilonia KL; Podell BK; Powers BE
J Am Vet Med Assoc; 2013 Sep; 243(6):795-7. PubMed ID: 24004225
[No Abstract] [Full Text] [Related]
5. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors.
Davies DR; Wyatt KM; Jardine JE; Robertson ID; Irwin PJ
J Am Anim Hosp Assoc; 2004; 40(2):124-30. PubMed ID: 15007048
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases.
O'Connell K; Thomson M
Vet Comp Oncol; 2013 Mar; 11(1):51-62. PubMed ID: 22235766
[TBL] [Abstract][Full Text] [Related]
7. A retrospective review of treatment and response of high-risk mast cell tumours in dogs.
Miller RL; Van Lelyveld S; Warland J; Dobson JM; Foale RD
Vet Comp Oncol; 2016 Dec; 14(4):361-370. PubMed ID: 25223579
[TBL] [Abstract][Full Text] [Related]
8. Canine oral mucosal mast cell tumours.
Elliott JW; Cripps P; Blackwood L; Berlato D; Murphy S; Grant IA
Vet Comp Oncol; 2016 Mar; 14(1):101-11. PubMed ID: 24215587
[TBL] [Abstract][Full Text] [Related]
9. "Masitinib" is safe and effective for the treatment of canine mast cell tumors.
Gentilini F
J Vet Intern Med; 2010; 24(1):6; author reply 7. PubMed ID: 20391634
[No Abstract] [Full Text] [Related]
10. Chemotherapy for dogs with lymph node metastasis from histiocytic sarcomas.
Moore AS; Taylor DP; Reppas G; Frimberger AE
Aust Vet J; 2017 Jan; 95(1-2):37-40. PubMed ID: 28124419
[TBL] [Abstract][Full Text] [Related]
11. Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment.
Welle MM; Bley CR; Howard J; Rüfenacht S
Vet Dermatol; 2008 Dec; 19(6):321-39. PubMed ID: 18980632
[TBL] [Abstract][Full Text] [Related]
12. [A mastocytoma in a dog].
Teske E; Kirpensteijn J; Rutteman GR
Tijdschr Diergeneeskd; 2007 Feb; 132(4):122-6. PubMed ID: 17366874
[No Abstract] [Full Text] [Related]
13. Radiation therapy for incompletely excised grade II canine mast cell tumors.
Poirier VJ; Adams WM; Forrest LJ; Green EM; Dubielzig RR; Vail DM
J Am Anim Hosp Assoc; 2006; 42(6):430-4. PubMed ID: 17088389
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgery.
Marconato L; Stefanello D; Kiupel M; Finotello R; Polton G; Massari F; Ferrari R; Agnoli C; Capitani O; Giudice C; Aresu L; Vasconi ME; Rigillo A; Sabattini S
Vet Comp Oncol; 2020 Sep; 18(3):409-415. PubMed ID: 31930651
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bone marrow aspirates from multiple sites for staging of canine lymphoma and mast cell tumours.
Aubry OA; Spangler EA; Schleis SE; Smith AN
Vet Comp Oncol; 2014 Mar; 12(1):58-66. PubMed ID: 22577893
[TBL] [Abstract][Full Text] [Related]
16. Canine mastocytoma: report of 8 cases diagnosed by fine needle cytology and clinicopathologic correlations.
Fulciniti F; Di Mattia D; Curcio MP; Bove P; Rota AM; Botti G
Acta Cytol; 2007; 51(4):616-20. PubMed ID: 17718137
[TBL] [Abstract][Full Text] [Related]
17. Cytologic comparison of the percentage of mast cells in lymph node aspirate samples from clinically normal dogs versus dogs with allergic dermatologic disease and dogs with cutaneous mast cell tumors.
Mutz ML; Boudreaux BB; Royal A; Merchant S; Pucheu-Haston C; Griffith EH; Gieger TL
J Am Vet Med Assoc; 2017 Aug; 251(4):421-428. PubMed ID: 28763275
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors.
Spugnini EP; Vincenzi B; Baldi F; Citro G; Baldi A
Anticancer Res; 2006; 26(6B):4585-9. PubMed ID: 17201181
[TBL] [Abstract][Full Text] [Related]
19. Canine subcutaneous mast cell tumor: characterization and prognostic indices.
Thompson JJ; Pearl DL; Yager JA; Best SJ; Coomber BL; Foster RA
Vet Pathol; 2011 Jan; 48(1):156-68. PubMed ID: 21078881
[TBL] [Abstract][Full Text] [Related]
20. Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumours.
Malone EK; Rassnick KM; Wakshlag JJ; Russell DS; Al-Sarraf R; Ruslander DM; Johnson CS; Trump DL
Vet Comp Oncol; 2010 Sep; 8(3):209-20. PubMed ID: 20691028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
